Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2023-05-15

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$512.2m reported value -13.7% vs Q4 2022
25positions
73.7%in top 10
4 new 5 added 2 reduced 7 sold out vs Q4 2022

Holdings, Q1 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 2,699,865 $68.7m13.41% 13.41% UnchangedShares held: Q3 2022 2.1m, Q4 2022 2.7m, Q1 2023 2.7m
2 COGENT BIOSCIENCES INC COM COGT COGT 4,884,977 $52.7m10.29% 10.29% AddedShares held: Q3 2022 4.0m, Q4 2022 4.0m, Q1 2023 4.9m +846.9k +846,860 21.0%
3 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 2,214,142 $48.5m9.47% 9.47% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 2.2m
4 TERNS PHARMACEUTICALS INC COM COM 3,619,522 $42.9m8.37% 8.37% ReducedShares held: Q3 2022 3.7m, Q4 2022 3.7m, Q1 2023 3.6m -88.4k -88,369 -2.4%
5 PLIANT THERAPEUTICS INC COM PLRX PLRX 1,430,000 $38.0m7.43% 7.43% AddedShares held: Q3 2022 1.1m, Q4 2022 1.1m, Q1 2023 1.4m +350.0k +350,000 32.4%
6 AMBRX BIOPHARMA INC SPONSORED ADS SPONSORED ADS 3,298,577 $29.4m5.74% 5.74% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 3.3m
7 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 3,517,125 $28.1m5.49% 5.49% UnchangedShares held: Q3 2022 3.3m, Q4 2022 3.5m, Q1 2023 3.5m
8 DICE THERAPEUTICS INC COM COM 819,000 $23.5m4.58% 4.58% UnchangedShares held: Q3 2022 765.0k, Q4 2022 819.0k, Q1 2023 819.0k
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 2,916,667 $22.9m4.48% 4.48% UnchangedShares held: Q3 2022 0, Q4 2022 2.9m, Q1 2023 2.9m
10 MERUS N V COM MRUS MRUS 1,226,214 $22.6m4.41% 4.41% UnchangedShares held: Q3 2022 0, Q4 2022 1.2m, Q1 2023 1.2m
11 CELCUITY INC COM CELC CELC 2,105,386 $21.6m4.21% 4.21% UnchangedShares held: Q3 2022 0, Q4 2022 2.1m, Q1 2023 2.1m
12 AEROVATE THERAPEUTICS INC COM COM 833,927 $16.8m3.28% 3.28% AddedShares held: Q3 2022 833.9k, Q4 2022 747.9k, Q1 2023 833.9k +86.1k +86,058 11.5%
13 CABALETTA BIO INC COM CABA CABA 1,973,251 $16.3m3.19% 3.19% AddedShares held: Q3 2022 0, Q4 2022 1.9m, Q1 2023 2.0m +78.0k +77,966 4.1%
14 VECTIVBIO HLDG AG ORD SHS ORD SHS 1,866,000 $15.9m3.10% 3.10% UnchangedShares held: Q3 2022 0, Q4 2022 1.9m, Q1 2023 1.9m
15 ANNEXON INC COM ANNX ANNX 3,220,050 $12.4m2.42% 2.42% UnchangedShares held: Q3 2022 3.2m, Q4 2022 3.2m, Q1 2023 3.2m
16 SAVARA INC COM SVRA SVRA 6,351,531 $12.4m2.42% 2.42% UnchangedShares held: Q3 2022 4.6m, Q4 2022 6.4m, Q1 2023 6.4m
17 MILESTONE PHARMACEUTICALS IN COM MIST MIST 2,208,812 $8.7m1.70% 1.70% UnchangedShares held: Q3 2022 2.4m, Q4 2022 2.2m, Q1 2023 2.2m
18 ACLARIS THERAPEUTICS INC COM ACRS ACRS 1,040,754 $8.4m1.64% 1.64% ReducedShares held: Q3 2022 4.6m, Q4 2022 4.6m, Q1 2023 1.0m -3.5m -3,523,208 -77.2%
19 THESEUS PHARMACEUTICALS INC COM COM 770,000 $6.8m1.34% 1.34% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 770.0k
20 TREVI THERAPEUTICS INC COM TRVI TRVI 3,050,022 $5.6m1.10% 1.10% UnchangedShares held: Q3 2022 3.1m, Q4 2022 3.1m, Q1 2023 3.1m
21 FULCRUM THERAPEUTICS INC COM FULC FULC 1,307,094 $3.7m0.73% 0.73% AddedShares held: Q3 2022 1.2m, Q4 2022 447.3k, Q1 2023 1.3m +859.8k +859,768 192.2%
22 LYRA THERAPEUTICS INC COM LYRA LYRA 924,170 $1.9m0.36% 0.36% UnchangedShares held: Q3 2022 924.2k, Q4 2022 924.2k, Q1 2023 924.2k
23 AVALO THERAPEUTICS INC COM NEW COM NEW 1,000,000 $1.8m0.34% 0.34% NewShares held: Q3 2022 0, Q4 2022 0, Q1 2023 1.0m
24 RALLYBIO CORP COM COM 268,532 $1.5m0.30% 0.30% UnchangedShares held: Q3 2022 268.5k, Q4 2022 268.5k, Q1 2023 268.5k
25 AFFIMED N V COM COM 1,428,571 $1.1m0.21% 0.21% UnchangedShares held: Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m

Sold out since Q4 2022

SecurityTickerShares held beforeValue then
AXSOME THERAPEUTICS INC AXSM AXSM 670,718 $51.7m670.7k shares
NOVAVAX INC NVAX NVAX 1,879,894 $19.3m1.9m shares
PROVENTION BIO INC PRVB PRVB 1,118,653 $11.8m1.1m shares
LIANBIO LIANY LIANY 4,793,047 $7.9m4.8m shares
MARINUS PHARMACEUTICALS INC MRNS MRNS 1,770,705 $7.0m1.8m shares
INOZYME PHARMA INC 2,709,987 $2.8m2.7m shares
ATYR PHARMA INC ATYR ATYR 1,171,436 $2.6m1.2m shares